Sunitinib-Teva 12.5 mg
Sunitinib-Teva 12.5 mg is a medicine authorised by Swissmedic under authorisation number 67781. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 February 2021 and the authorisation is valid without a time limit. ATC code L01EX01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67781 |
|---|---|
| Name | Sunitinib-Teva 12.5 mg |
| Full name | Sunitinib-Teva 12.5 mg, Hartkapseln |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EX01 |
| First authorisation | 15 February 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sunitinib-Teva 12.5 mg, Hartkapseln | A | 15 February 2021 |
| 2 | Sunitinib-Teva 25 mg, Hartkapseln | A | 15 February 2021 |
| 3 | Sunitinib-Teva 37.5 mg, Hartkapseln | A | 15 February 2021 |
| 4 | Sunitinib-Teva 50 mg, Hartkapseln | A | 15 February 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | L01EX01 | 07.16.1. | A |
| 2 | 28 | Kapsel(n) | L01EX01 | 07.16.1. | A |
| 3 | 28 | Kapsel(n) | L01EX01 | 07.16.1. | A |
| 4 | 28 | Kapsel(n) | L01EX01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sunitinib-Teva 12.5 mg authorised in Switzerland?
Yes. Sunitinib-Teva 12.5 mg is authorised by Swissmedic under authorisation number 67781, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sunitinib-Teva 12.5 mg have?
Sunitinib-Teva 12.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Sunitinib-Teva 12.5 mg?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.